Piermont Capital Management Inc. - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 147 filers reported holding ANI PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 10.74 and the average weighting 0.1%.

Quarter-by-quarter ownership
Piermont Capital Management Inc. ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$298,000
-4.2%
4,460
-16.5%
0.09%
-12.5%
Q1 2018$311,000
-21.9%
5,340
-13.5%
0.10%
-20.6%
Q4 2017$398,000
+16.0%
6,170
-5.5%
0.13%
+14.9%
Q3 2017$343,000
-43.8%
6,530
-49.9%
0.11%
-34.5%
Q2 2017$610,000
-19.4%
13,040
-14.7%
0.17%
-3.3%
Q1 2017$757,000
+72.4%
15,290
+111.2%
0.18%
+80.0%
Q4 2016$439,000
-10.4%
7,240
-1.9%
0.10%
-13.8%
Q3 2016$490,0007,3800.12%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
AIGH Capital Management LLC 272,801$15,838,8267.50%
Global Alpha Capital Management Ltd. 525,528$30,512,1563.06%
Rubric Capital Management LP 847,011$49,177,4591.84%
Ranger Investment Management 426,848$24,782,7951.64%
Parkman Healthcare Partners LLC 111,802$6,491,2241.19%
MARATHON CAPITAL MANAGEMENT 71,670$4,161,1601.05%
Mesirow Financial Investment Management, Inc. 3,862$224,2280.98%
Deep Track Capital, LP 400,000$23,224,0000.90%
1492 Capital Management LLC 18,178$1,055,4150.68%
Phocas Financial Corp. 75,213$4,367,0000.64%
View complete list of ANI PHARMACEUTICALS INC shareholders